1. Home
  2. RBBN vs IVA Comparison

RBBN vs IVA Comparison

Compare RBBN & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RBBN
  • IVA
  • Stock Information
  • Founded
  • RBBN 1997
  • IVA 2011
  • Country
  • RBBN United States
  • IVA France
  • Employees
  • RBBN N/A
  • IVA N/A
  • Industry
  • RBBN EDP Services
  • IVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • RBBN Technology
  • IVA Health Care
  • Exchange
  • RBBN Nasdaq
  • IVA Nasdaq
  • Market Cap
  • RBBN 671.1M
  • IVA 769.0M
  • IPO Year
  • RBBN 2000
  • IVA 2020
  • Fundamental
  • Price
  • RBBN $2.82
  • IVA $4.21
  • Analyst Decision
  • RBBN Strong Buy
  • IVA Strong Buy
  • Analyst Count
  • RBBN 4
  • IVA 8
  • Target Price
  • RBBN $6.00
  • IVA $16.13
  • AVG Volume (30 Days)
  • RBBN 876.2K
  • IVA 492.4K
  • Earning Date
  • RBBN 10-22-2025
  • IVA 09-29-2025
  • Dividend Yield
  • RBBN N/A
  • IVA N/A
  • EPS Growth
  • RBBN N/A
  • IVA N/A
  • EPS
  • RBBN N/A
  • IVA N/A
  • Revenue
  • RBBN $868,592,000.00
  • IVA $19,929,536.00
  • Revenue This Year
  • RBBN $5.02
  • IVA N/A
  • Revenue Next Year
  • RBBN $5.74
  • IVA N/A
  • P/E Ratio
  • RBBN N/A
  • IVA N/A
  • Revenue Growth
  • RBBN 7.38
  • IVA N/A
  • 52 Week Low
  • RBBN $2.78
  • IVA $2.11
  • 52 Week High
  • RBBN $5.38
  • IVA $7.98
  • Technical
  • Relative Strength Index (RSI)
  • RBBN 27.22
  • IVA 44.77
  • Support Level
  • RBBN $2.94
  • IVA $3.55
  • Resistance Level
  • RBBN $3.14
  • IVA $4.10
  • Average True Range (ATR)
  • RBBN 0.12
  • IVA 0.28
  • MACD
  • RBBN -0.03
  • IVA 0.00
  • Stochastic Oscillator
  • RBBN 5.19
  • IVA 71.26

About RBBN Ribbon Communications Inc.

Ribbon Communications Inc provides network solutions to service providers and enterprises. The company enables service providers and enterprises to modernize their communications networks and provide secure real-time communications solutions to their customers and employees. The company has two separate lines of business; the Cloud and Edge segment, and the IP Optical Networks segment. The majority of the revenue for the company is generated from its Cloud and Edge segment that provides secure and reliable software and hardware products, solutions, and services for VoIP communications, Voice Over LTE among others to service providers and enterprise customers. The company generates majority of its revenue from United States.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: